Sana Biotechnology Inc vs Victoria's Secret & Co — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Victoria's Secret & Co trades at $87.75 (market cap $6.95B). The key difference: Victoria's Secret & Co is far larger — about 8× Sana Biotechnology Inc's market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | VSXY | |
|---|---|---|
Market Cap | $873.84M | $6.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $88.50 |
52-Week Low | $2.68 | $18.72 |
Enterprise Value | $848.03M | $9.59B |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →